IMMUNE REDIRECTION, UNFOLDED PROTEIN RESPONSE MODULATION, AND CELL-BASED DELIVERY AS STRATEGIES TO ENHANCE THE THERAPEUTIC EFFICACY OF ONCOLYTIC VACCINIA VIRUS IMMUNOTHERAPY